Literature DB >> 27041335

Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population.

Seung Taek Lim1, Jung Eun Choi2, Sei Joong Kim3, Hyun Ah Kim4, Ji Young Kim5, Heung Kyu Park6, Young Jin Suh7.   

Abstract

Previous studies have not considered the axillary lymph node status when investigating the prognostic role of tumor location according to each molecular subtype. The present study aimed to investigate the prognostic implication of tumor location according to each molecular subtype in Korean invasive ductal carcinoma (IDC) patients with axillary lymph node metastasis. Data from 7856 Korean IDC women with axillary lymph node metastasis were retrospectively analyzed. According to tumor location, patients were divided into the following groups: upper-outer quadrant, lower-outer quadrant, upper-inner quadrant, lower-inner quadrant (LIQ), and central group. Overall survival (OS) and breast cancer-specific survival (BCSS) were evaluated according to tumor location and molecular subtype. A subgroup analysis based on tumor size categorization was also performed. The patients' mean age was 47.97 ± 9.64 years, and the median follow-up time was 90 months. The LIQ group showed significantly worse prognosis in OS and BCSS (76.4 and 83.3 %, respectively) compared with the other groups, which was only significant in human epidermal growth factor receptor 2 (HER2) overexpression and triple-negative (TN) subtypes. In the subgroup analysis according to tumor size, the LIQ group showed a significantly worse prognosis in OS and BCSS compared with the other groups, in HER2 and TN subtypes, and only in patients with more than T2 stage. In Korean IDC patients with axillary lymph node metastasis, LIQ tumor location was associated with poor prognosis among those with HER2 and TN molecular subtypes and especially in those with more than T2 stage.

Entities:  

Keywords:  Breast neoplasm; Molecular subtype; Prognosis; Tumor location

Mesh:

Substances:

Year:  2016        PMID: 27041335     DOI: 10.1007/s10549-016-3771-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  5 in total

1.  Prognostic significance of the primary tumor site and immune indexes in patients with estrogen receptor-positive, human epidermal growth factor receptor-2-negative breast cancer.

Authors:  Xinming Song; Jianli Ma; Han Zhang; Qingyuan Zhang
Journal:  Gland Surg       Date:  2020-10

2.  Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy.

Authors:  Ji Hyun Chang; Wan Jeon; Kyubo Kim; Kyung Hwan Shin; Wonshik Han; Dong-Young Noh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang
Journal:  J Breast Cancer       Date:  2016-12-23       Impact factor: 3.588

3.  Clinical and epidemiologic factors associated with breast cancer and its subtypes among Northeast Chinese women.

Authors:  Dong-Man Ye; Qiang Li; Tao Yu; Hao-Tian Wang; Ya-Hong Luo; Wen-Qing Li
Journal:  Cancer Med       Date:  2019-10-23       Impact factor: 4.452

4.  Distance Between the Tumour and Nipple as a Predictor of Axillary Lymph Node Involvement in Breast Cancer.

Authors:  Jiqiao Yang; Qianru Yang; Arjudeb Mukherjee; Qing Lv
Journal:  Cancer Manag Res       Date:  2021-01-11       Impact factor: 3.989

5.  Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer.

Authors:  Gulijire Tailaiti; Gulanbaier Maimaiti; Youlituzi Aikeremu; Batuer Tuerdi
Journal:  Int J Gen Med       Date:  2021-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.